tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Mainwaring, 5 are a HOLD (83.33%), 1 are a BUY (16.67%).
Analyst James Mainwaring, currently employed at ATLANTIC EQUITIES, carries an average stock price target met ratio of 44.44% that have a potential upside of 3.6% achieved within 89 days.
James Mainwaring’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 01-Jun-2022.
Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) at 4/12/2022. The price target of $135 was fulfilled within 127 days with a profit of $10.44 (8.38%) receiving and performance score of 0.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$116
$7.37 (6.78%)
$155
19 days ago
(21-Apr-2025)
14/20 (70%)
$15.74 (15.70%)
386
Hold
$115
$6.37 (5.86%)
$145
1 months ago
(10-Apr-2025)
11/13 (84.62%)
$15.05 (15.06%)
143
Buy
$159
$50.37 (46.37%)
$136
2 months 13 days ago
(27-Feb-2025)
9/15 (60%)
$31.92 (25.12%)
112
Hold
$150
$41.37 (38.08%)
$147
4 months 27 days ago
(13-Dec-2024)
8/8 (100%)
$11.26 (8.12%)
89
Buy
$160
$51.37 (47.29%)
$155
5 months 14 days ago
(26-Nov-2024)
0/2 (0%)
$25.88 (19.30%)
What Year was the first public recommendation made by James Mainwaring?
